< Back to search
Filter
1

Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

for
Ovarian Cancer, Endometrial Cancer,
Location: Boston MA, Fairfax VA, Orlando FL, Nashville TN,
Sponsor: ArriVent BioPharma, Inc.

Sex: Female

Age: 18+

Code: NCT07755436

Phase1, Recruiting

A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

for
Platinum-resistant Ovarian Cancer
Location: Boston MA, New Haven CT, Fairfax VA, Sarasota FL,
Sponsor: Stemline Therapeutics, Inc.

Sex: Female

Age: 18+

Code: NCT07226427

Phase1, Recruiting

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

for
Platinum-resistant Ovarian Cancer,
Location: Montreal, Toronto, Pittsburgh PA, Grand Rapids MI,
Sponsor: MacroGenics

Sex: Female

Age: 18+

Code: NCT06730347

Phase2, Recruiting

A Study of MGC026 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor, Advanced Cancer, Metastatic Cancer,
Location: Lake Success NY, Grand Rapids MI, Houston TX,
Sponsor: MacroGenics

Sex: All

Age: 18+

Code: NCT06242470

Phase1, Recruiting

Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer

for
Metastatic Malignant Solid Neoplasm,
Location: Boston MA, Deerfield Beach FL, Coral Gables FL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04585958

Phase1, Recruiting

Interested in new platinum-resistant ovarian cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer

for
Malignant Ovarian Epithelial Tumor,
Location: Detroit MI, Flint MI
Sponsor: Ira Winer

Sex: Female

Age: 18+

Code: NCT04055649

Phase2, Recruiting